Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

2015856 citationsJournal Articlehybrid Open Access

Authors

The National Institute for Health Research through the UK National Cancer Research Network, the Medical Research Council, and Roche.

Good health and well-being

Published in: The Lancet Oncology

Volume 16, Issue 8, pp. 928-936

Field-Weighted Citation Impact: 93.15